Instil Bio, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-82.0M | $-102.7M | $20.7M | $18.2M |
| FY2024 | $-55.7M | $-55.7M | $0 | $17.3M |
| FY2025 | $-36.6M | $-36.6M | — | $8.7M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-82.0M | $-102.7M | $20.7M | $18.2M |
| FY2024 | $-55.7M | $-55.7M | $0 | $17.3M |
| FY2025 | $-36.6M | $-36.6M | — | $8.7M |